Safaa Ramadan

1.8k total citations
41 papers, 893 citations indexed

About

Safaa Ramadan is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Safaa Ramadan has authored 41 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 11 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Safaa Ramadan's work include Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Acute Myeloid Leukemia Research (9 papers). Safaa Ramadan is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Acute Myeloid Leukemia Research (9 papers). Safaa Ramadan collaborates with scholars based in Italy, Egypt and United Kingdom. Safaa Ramadan's co-authors include Gerry Melino, Eleonora Candi, Maria Valeria Catani, Richard A. Knight, Alessandro Terrinoni, Francesco Lo‐Coco, Alessandra Rufini, Marco Ranalli, Andréa Paradisi and Luigi Giusto Spagnoli and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Safaa Ramadan

40 papers receiving 878 citations

Peers

Safaa Ramadan
Mojtaba Akhtari United States
Ellen Moore United States
Murali Janakiram United States
Jason Stadanlick United States
James Strauss United States
Jill Giles‐Komar United States
Mojtaba Akhtari United States
Safaa Ramadan
Citations per year, relative to Safaa Ramadan Safaa Ramadan (= 1×) peers Mojtaba Akhtari

Countries citing papers authored by Safaa Ramadan

Since Specialization
Citations

This map shows the geographic impact of Safaa Ramadan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Safaa Ramadan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Safaa Ramadan more than expected).

Fields of papers citing papers by Safaa Ramadan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Safaa Ramadan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Safaa Ramadan. The network helps show where Safaa Ramadan may publish in the future.

Co-authorship network of co-authors of Safaa Ramadan

This figure shows the co-authorship network connecting the top 25 collaborators of Safaa Ramadan. A scholar is included among the top collaborators of Safaa Ramadan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Safaa Ramadan. Safaa Ramadan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Phillips, Tycel, Michael Wang, Tadeusz Robak, et al.. (2024). Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naive or relapsed / refractory mantle cell lymphoma: phase Ib trial. Haematologica. 110(3). 715–724. 3 indexed citations
2.
Dreyling, Martin, Jiřı́ Mayer, David Belada, et al.. (2024). High-Risk Subgroups and MRD: An Updated Analysis of the Phase 3 ECHO Trial of Acalabrutinib with Bendamustine/Rituximab in Previously Untreated Mantle Cell Lymphoma. Blood. 144(Supplement 1). 1626–1626. 2 indexed citations
3.
Mazzara, Saveria, Laura Lavinia Travaini, Francesca Botta, et al.. (2023). Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL. Blood Advances. 7(4). 630–643. 6 indexed citations
4.
Ramadan, Safaa. (2021). Prognostic Impact Of Baseline Immunologic Profile In Aggressive B-cell Non-Hodgkin’s Lymphomas. Mediterranean Journal of Hematology and Infectious Diseases. 13(1). e2021018–e2021018. 2 indexed citations
5.
Gallamini, Andrea, Martin Hutchings, & Safaa Ramadan. (2016). Clinical presentation and staging of Hodgkin lymphoma. Seminars in Hematology. 53(3). 148–154. 15 indexed citations
6.
Cornely, Oliver A., Bertrand Gachot, Hamdi Akan, et al.. (2015). Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). Clinical Infectious Diseases. 61(3). 324–331. 97 indexed citations
7.
Maraldo, Maja V., Francesco Giusti, Ivan R. Vogelius, et al.. (2015). Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials. The Lancet Haematology. 2(11). e492–e502. 110 indexed citations
8.
Khorshid, Ola & Safaa Ramadan. (2015). EFFICACY AND SAFETY OF CLADRIBINE: SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION IN HAIRY CELL LEUKEMIA PATIENTS. Mediterranean Journal of Hematology and Infectious Diseases. 7(1). e2015058–e2015058. 5 indexed citations
9.
Morton, Lindsay M., Anthony J. Swerdlow, Michael Schaapveld, et al.. (2014). Current knowledge and future research directions in treatment-related second primary malignancies. European Journal of Cancer Supplements. 12(1). 5–17. 46 indexed citations
11.
Moser, Elizabeth Charlotte, et al.. (2013). Cancer Survivorship: A Positive Side Effect of More Successful Cancer Treatment. European Oncology & Haematology. 9(2). 74–74. 2 indexed citations
12.
Lengfelder, Eva, Francesco Lo‐Coco, Lionel Adès, et al.. (2013). Arsenic Trioxide-Based Therapy Of Relapsed Acute Promyelocytic Leukemia: Updated Results Of The European Registry Of Relapsed APL (PROMYSE). Blood. 122(21). 1406–1406. 3 indexed citations
13.
Ramadan, Safaa, Laura Cicconi, Nélida I. Noguera, et al.. (2012). Analysis of mutational status, SNP rs16754, and expression levels of Wilms tumor 1 (WT1) gene in acute promyelocytic leukemia. Annals of Hematology. 91(12). 1855–1860. 17 indexed citations
14.
Khorshid, Ola, et al.. (2011). CLINICAL FEATURES AND CLINICAL OUTCOME OF ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS TREATED AT CAIRO NATIONAL CANCER INSTITUTE IN EGYPT. SHILAP Revista de lepidopterología. 3(1). e2011060–e2011060. 6 indexed citations
15.
Lena, Anna Maria, Rita Cipollone, Ivano Amelio, et al.. (2010). Skn-1a/Oct-11 and ΔNp63α exert antagonizing effects on human keratin expression. Biochemical and Biophysical Research Communications. 401(4). 568–573. 28 indexed citations
16.
Lo‐Coco, Francesco, Tamer M. Fouad, & Safaa Ramadan. (2010). Acute Leukemia in Women. Women s Health. 6(2). 239–249. 2 indexed citations
17.
Ammatuna, Emanuele, Pau Montesinos, Syed K. Hasan, et al.. (2010). Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis. Haematologica. 96(4). 621–625. 14 indexed citations
18.
Ramadan, Safaa, Alessandro Terrinoni, Maria Valeria Catani, et al.. (2005). p73 induces apoptosis by different mechanisms. Biochemical and Biophysical Research Communications. 331(3). 713–717. 127 indexed citations
19.
Smoller, Bruce R., et al.. (2004). Evaluation of anti‐thrombomodulin antibody as a tumor marker for vascular neoplasms. Journal of Cutaneous Pathology. 31(10). 652–656. 7 indexed citations
20.
Cadot, Bruno, Alessandra Rufini, Safaa Ramadan, et al.. (2004). Overexpressed transglutaminase 5 triggers cell death. Amino Acids. 26(4). 405–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026